Table 2 Trends of biochemical measurements, body and anthropometric composition in follow-ups until two years post-operation.

From: Impact of bariatric surgery on liver fibrosis indices among type 2 diabetes patients in a national cohort

 

Preoperative

(N = 1205)

3-months visit

(N = 1205)

6-months visit

(N = 947)

One-year visit

(N = 588)

Two-year visit

(N = 263)

BMI (kg/m2)

44.75 (6.89)

36.19 (9.01)

32.55 (6.93)

30.14 (5.19)

30.79 (12.37)

Weight (kg)

118.74 (22.77)

94.71 (18.85)

86.11 (16.77)

79.54 (15.57)

80.48 (16.45)

TWL%

20.27 (4.54)

27.47 (5.41)

32.86 (7.45)

32.14 (8.77)

PLT *103 (IU/L)

279.04 (68.97)

255.08 (66.54)

257.01 (66.01)

248.24 (62.52)

247.23 (66.44)

FBG (IU/L)

144.05 (51.82)

106.80 (29.10)

99.90 (23.11)

94.74 (38.50)

94.34 (19.09)

HbA1c (%)

7.28 (1.79)

5.87 (1.02)

5.64 (0.92)

5.54 (0.88)

5.56 (0.89)

AST (IU/L)

28.16 (17.87)

24.67 (10.87)

20.42 (9.06)

21.37 (8.51)

22.76 (9.46)

ALT (IU/L)

35.45 (26.66)

27.01 (16.73)

19.54 (12.55)

21.95 (11.75)

22.31 (13.88)

TC (IU/L)

187.33 (43.69)

176.39 (39.92)

176.01 (37.79)

172.89 (35.05)

176.76 (34.09)

HDL-C (IU/L)

45.70 (12.76)

42.31 (10.96)

46.55 (18.64)

50.26 (11.36)

51.93 (12.03)

LDL-C (IU/L)

106.67 (35.45)

105.03 (37.67)

102.99 (31.56)

99.16 (28.81)

98.89 (28.32)

Triglyceride (IU/L)

189.71 (101.66)

152.02 (57.30)

127.61 (50.95)

111.24 (55.09)

113.49 (62.17)

Cr (IU/L)

0.97 (0.88)

0.93 (0.21)

0.92 (0.50)

1.34 (6.42)

0.90 (0.27)

Albumin (IU/L)

4.45 (1.67)

4.40 (1.64)

4.34 (1.86)

4.46 (4.02)

4.38 (2.29)

  1. Data are presented as mean ± SD.
  2. BMI: body mass index; TWL%: total weight loss; FBG: fasting blood glucose; HbA1c: hemoglobin A1C; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; AST: aspartate aminotransferase; ALT: alanine aminotransferase.